DDonaldson designs and supplies filtration and contamination control solutions for air, liquids, and gases to protect equipment, people, and processes. Its products, including filters, housings, and filtration systems, trap dust and contaminants as fluids flow through them. It stands out through a global footprint and a broad portfolio of technologies, backed by engineering expertise and strong customer support. Its goal is to help customers solve contamination challenges and improve safety, efficiency, and productivity across many industries.
Work here?Claim your company
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Bloomington, MN
Founded
1915
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$650M
Above
Industry Average
Funded Over
2 Rounds
Donaldson Company, Inc. (NYSE: DCI) has launched Alpha-Pore technology, a sterile filtration platform designed to extend filter life while maintaining performance. The company announced the product on November 2, 2026. In controlled tests, the filters ran up to 2.5 times longer than conventional polyethersulfone cartridge designs. They are built to withstand up to 150 sterilisation-in-place cycles and keep a stable differential pressure profile. Donaldson says the platform is validated for consistent microbiological retention in food and beverage processing. Fewer changeouts should help manufacturers work more efficiently. "Our customers have traditionally faced tradeoffs between extended filter life and maintaining critical process performance," said Nathan Zambon, senior director of product and technology at Donaldson. Alpha-Pore joins the company's LifeTec filter element portfolio.
Donaldson introduces Alpha-Pore(TM) technology platform for Extended Sterile Filtration performance. Published on 11/02/2026 at 09:36 am EST Business Wire Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration products and solutions, today announced Alpha-Pore(TM) technology, a next generation sterile filtration platform engineered to extend filter service life while maintaining critical process performance. Built for critical applications, Alpha-Pore technology enables longer filter run time compared with competitive single- and dual-layer polyethersulfone (PES) membrane filters, while maintaining flow characteristics, sterility assurance, and process integrity.* The platform is designed to help manufacturers improve operational efficiency through fewer changeouts and more consistent performance over time. Engineered for Extended Performance Sterile filtration processes often require balancing run time with key performance parameters such as flow, differential pressure, and contaminant retention. Alpha-Pore technology is designed to achieve all three. By optimizing pore structure and filter architecture, Alpha-Pore technology supports sustained performance throughout the filter lifecycle - helping maintain stable operation under challenging conditions. Key Benefits Include: * Up to 2.5x longer run time under controlled test conditions versus conventional PES cartridge designs* * Validated for consistent micro-biological retention efficiency for process food and beverage applications * Stable differential pressure profile compared to equivalent single-layer products * Robust construction engineered to withstand up to 150 sterilization-in-place (SIP) cycles A Platform Approach to Sterile Filtration As a new platform within the Donaldson LifeTec(TM) filter element portfolio, Alpha-Pore technology is engineered to improve run time performance over traditional single- and dual-layer filters, while maintaining the filtration characteristics required for sterile applications. "Our customers have traditionally faced tradeoffs between extended filter life and maintaining critical process performance," said Nathan Zambon, Senior Director of Product & Technology at Donaldson. "Alpha-Pore technology is designed to help overcome those challenges, enabling longer run times while supporting the sterility, flow performance, and process consistency customers depend on." About Donaldson Process Filtration Donaldson Process Filtration is a global provider of filtration solutions for liquid, compressed air and gas, sterile air and venting, and steam applications. Serving critical industries including food and beverage, pharmaceutical, healthcare, microelectronics, and data centers, Donaldson helps customers protect process and product integrity and maintain consistent operational performance. About Donaldson Company, Inc. Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions, serving a broad range of industries and advanced markets. Diverse, skilled employees at more than 150 locations on six continents partner with customers - from small business owners to research and development organizations and the world's largest OEM brands. Donaldson solves complex filtration challenges through three primary segments: Mobile Solutions, Industrial Solutions and Life Sciences. Additional information is available at www.Donaldson.com. * Results are based on internal laboratory testing and comparisons with multiple leading competitor single- and dual-layer PES filter cartridges. Performance may vary depending on operating conditions and application requirements. View source version on businesswire.com: https://www.businesswire.com/news/home/20261102753918/en/ (C) Business Wire - 2026
Donaldson Company, Inc. has signed a Note Purchase Agreement with institutional investors that allows it to issue up to $1.5 billion in senior unsecured notes across multiple series. The company disclosed the October 27, 2026 deal in an 8-K filing. The first series, $250 million of Series 2026-A Notes, is a private placement expected to close on January 12, 2027, subject to closing conditions. It has three fixed-rate tranches: — $125 million at 5.93%, maturing in 2032 — $75 million at 6.10%, maturing in 2034 — $50 million at 6.23%, maturing in 2037 Interest is paid semiannually. Donaldson may prepay the notes with a Make-Whole Amount, and must offer to prepay them at par plus accrued interest if control of the company changes.
Donaldson Company reported record fiscal 2026 results with annual sales rising 5% to $3.9 billion and adjusted earnings per share increasing 8% to $3.98. Operating margin reached a record 16%. Fourth-quarter sales exceeded $1 billion for the first time, up 8% year-over-year. Adjusted EPS rose 12% to $1.15, whilst operating margin expanded to 17.5%. The company's acquisition of Facet Filtration, completed in May 2026, added roughly three percentage points to fourth-quarter sales growth but reduced quarterly EPS by $0.06. Management expects approximately $0.12 of dilution in fiscal 2027. For fiscal 2027, Donaldson forecasts sales growth of 5.5% to 9.5%, with EPS projected between $4.22 and $4.38. Operating margin is expected to reach 16.6% to 17.2%.
Donaldson sales hit $1.1 billion as growth reaches 8%. * Donaldson Company (NYSE:DCI) reported fiscal Q4 2026 sales of $1.1 billion, up 8% year over year. * GAAP EPS reached $1.10, up 13.4%, while adjusted EPS increased 11.7% to $1.15. * The company provided fiscal 2027 guidance for sales growth of 5.5%-9.5% and EPS of $4.22-$4.38. Donaldson Company (NYSE:DCI) reported fiscal fourth-quarter 2026 sales of $1.1 billion, up 8% year over year, with GAAP earnings per share increasing to $1.10. The company's adjusted EPS reached $1.15, up 11.7% year over year, including $0.06 of dilution from its Facet acquisition, while fiscal 2026 full-year sales increased 5.3% to $3.9 billion. Donaldson reported that Industrial Solutions improved operational performance with a 300 basis point sequential increase in earnings before tax margin, while Facet contributed approximately $30 million in sales and improved enterprise gross margin mix. The company returned approximately $37 million to shareholders through dividends during the quarter and paid down $102 million of Facet-related debt, while completing the Facet acquisition during fiscal 2026. Donaldson reported full-year fiscal 2026 GAAP net earnings of $453.8 million, compared with $367 million in fiscal 2025, and stated that it expects fiscal 2027 sales growth of 5.5%-9.5% and EPS between $4.22 and $4.38. Frequently asked questions. DCI signals
Find jobs on Simplify and start your career today
We update Donaldson's jobs every few hours, so check again soon!Browse all jobs
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Bloomington, MN
Founded
1915
Find jobs on Simplify and start your career today
We update Donaldson's jobs every few hours, so check again soon!Browse all jobs